Prognostic and predictive value of copy number alterations in invasive breast cancer as determined by multiplex ligation-dependent probe amplification

Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials

(2013)   LANCET

Detection limits of DNA copy number alterations in heterogeneous cell populations

(2012) Oscar Krijgsman et al.   CELLULAR ONCOLOGY

Chromosome 1q25.3 copy number alterations in primary breast cancers detected by multiplex ligation-dependent probe amplification and allelic imbalance assays and its comparison with fluorescent in situ hybridization assays

(2012) Emilia Wiechec et al.   CELLULAR ONCOLOGY

Prognostic and predictive role of ESR1 status for postmenopausal patients with endocrine-responsive early breast cancer in the Danish cohort of the BIG 1-98 trial

(2011) B. Ejlertsen et al.   ANNALS OF ONCOLOGY

Characterisation of amplification patterns and target genes at chromosome 11q13 in CCND1-amplified sporadic and familial breast tumours

(2011) Karolina Holm et al.   BREAST CANCER RESEARCH AND TREATMENT

Validation of the Multiplex Ligation-dependent Probe Amplification (MLPA) Technique for the Determination of HER2 Gene Amplification in Breast Cancer

(2011) Gelareh Farshid et al.   DIAGNOSTIC MOLECULAR PATHOLOGY

Gene amplification of ESR1 in breast cancers-fact or fiction? A fluorescence in situ hybridization and multiplex ligation-dependent probe amplification study

(2011) Akishi Ooi et al.   JOURNAL OF PATHOLOGY

Breast and cervical cancer in 187 countries between 1980 and 2010: a systematic analysis

(2011) Mohammad H Forouzanfar et al.   LANCET

ESR1 amplification is rare in breast cancer and is associated with high grade and high proliferation: a multiplex ligation-dependent probe amplification study

(2011) Cathy B. Moelans et al.   CELLULAR ONCOLOGY

Amplification of ESR1 may predict resistance to adjuvant tamoxifen in postmenopausal patients with hormone receptor positive breast cancer

(2010) Kirsten Vang Nielsen et al.   BREAST CANCER RESEARCH AND TREATMENT

FGFR1 Amplification Drives Endocrine Therapy Resistance and Is a Therapeutic Target in Breast Cancer

(2010) N. Turner et al.   CANCER RESEARCH

Predictive markers of anthracycline benefit: a prospectively planned analysis of the UK National Epirubicin Adjuvant Trial (NEAT/BR9601)

(2010) John MS Bartlett et al.   LANCET ONCOLOGY

Molecular profiling of invasive breast cancer by multiplex ligation-dependent probe amplification-based copy number analysis of tumor suppressor and oncogenes

(2010) Cathy B Moelans et al.   MODERN PATHOLOGY

MTDH Activation by 8q22 Genomic Gain Promotes Chemoresistance and Metastasis of Poor-Prognosis Breast Cancer

(2009) Guohong Hu et al.   CANCER CELL

Simultaneous detection of TOP2A and HER2 gene amplification by multiplex ligation-dependent probe amplification in breast cancer

(2009) Cathy B Moelans et al.   MODERN PATHOLOGY

The value ofTOP2Agene copy number variation as a biomarker in breast cancer: Update of DBCG trial 89D

(2008) Kirsten Vang Nielsen et al.   ACTA ONCOLOGICA